{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:51:44Z","timestamp":1786114304667,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474018"],"award-info":[{"award-number":["82474018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.coph.2026.102645","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:03:41Z","timestamp":1781460221000},"page":"102645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the ischemic cascade: Review on approved and investigational stroke therapies"],"prefix":"10.1016","volume":"89","author":[{"given":"Ruoyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1896-097X","authenticated-orcid":false,"given":"Zhifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2026.102645_bib1","first-page":"783","article-title":"Summary of report on stroke prevention and treatment in China","volume":"20","year":"2023","journal-title":"Chin J Cerebrovasc Dise"},{"key":"10.1016\/j.coph.2026.102645_bib2","series-title":"Health data overview for the people\u2019s Republic of China","year":"2024"},{"key":"10.1016\/j.coph.2026.102645_bib3","series-title":"World health statistics 2024: monitoring health for the SDGs, sustainable development goals","year":"2024"},{"key":"10.1016\/j.coph.2026.102645_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global Burden of Disease Study 2019","volume":"20","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2402980","article-title":"Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy","volume":"391","author":"Xiong","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2026.102645_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMoa2310392","article-title":"Tenecteplase for stroke at 4.5 to 24 hours with perfusion-imaging selection","volume":"390","author":"Albers","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2026.102645_bib7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2024.0572","article-title":"Endovascular thrombectomy for large ischemic stroke across ischemic injury and penumbra profiles","volume":"331","author":"Sarraj","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2026.102645_bib8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jacc.2023.07.025","article-title":"Antithrombotic therapy for primary and secondary prevention of ischemic stroke: JACC state-of-the-art review","volume":"82","author":"Greco","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.coph.2026.102645_bib9","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3390\/ijms24054334","article-title":"Neuroprotective strategies for ischemic stroke-future perspectives","volume":"24","author":"Haupt","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102645_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00709-019-01439-2","article-title":"Ischemic stroke and mitochondria: mechanisms and targets","volume":"257","author":"Andrabi","year":"2020","journal-title":"Protoplasma"},{"key":"10.1016\/j.coph.2026.102645_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","article-title":"Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.coph.2026.102645_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCRESAHA.121.319412","article-title":"CircOGDH is a penumbra biomarker and therapeutic target in acute ischemic stroke","volume":"130","author":"Liu","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2026.102645_bib13","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.7150\/thno.100090","article-title":"Hypoxanthine is a metabolic biomarker for inducing GSDME-dependent pyroptosis of endothelial cells during ischemic stroke","volume":"14","author":"Ye","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.coph.2026.102645_bib14","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/STROKEAHA.123.041783","article-title":"BAG3 overexpression attenuates ischemic stroke injury by activating autophagy and inhibiting apoptosis","volume":"54","author":"Liu","year":"2023","journal-title":"Stroke"},{"issue":"Pt A","key":"10.1016\/j.coph.2026.102645_bib15","article-title":"Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke","volume":"113","author":"Hu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coph.2026.102645_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41590-023-01711-x","article-title":"Analysis of brain and blood single-cell transcriptomics in acute and subacute phases after experimental stroke","volume":"25","author":"Garcia-Bonilla","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coph.2026.102645_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41467-023-36008-y","article-title":"FTO-dependent m6A modification of Plpp3 in circSCMH1-regulated vascular repair and functional recovery following stroke","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102645_sref18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/cvr\/cvad126","article-title":"Activation of endothelial TRPM2 exacerbates blood-brain barrier degradation in ischemic stroke","volume":"120","author":"Zong","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.coph.2026.102645_sref19","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMoa2413344","article-title":"Alteplase for posterior circulation ischemic stroke at 4.5 to 24 hours","volume":"392","author":"Yan","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2026.102645_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jama.2022.1645","article-title":"Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial","volume":"327","author":"Ren\u00fa","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2026.102645_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12916-024-03820-2","article-title":"Effect of intravenous urokinase vs best medicine treatment on functional outcome for patients with acute minor stroke (TRUST): a randomized controlled trial","volume":"23","author":"Tao","year":"2025","journal-title":"BMC Med"},{"key":"10.1016\/j.coph.2026.102645_bib22","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1056\/NEJMoa2400314","article-title":"Reteplase versus alteplase for acute ischemic stroke","volume":"390","author":"Li","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2026.102645_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/STROKEAHA.123.045193","article-title":"Safety and efficacy of reteplase versus alteplase for acute ischemic stroke: a phase 2 randomized controlled trial","volume":"55","author":"Li","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.coph.2026.102645_bib24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(22)02600-9","article-title":"Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial","volume":"401","author":"Wang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2026.102645_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/ana.27303","article-title":"Intravenous thrombolysis use before inter-facility transfer for thrombectomy: association with efficacy and safety outcomes","author":"Seners","year":"2025","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91469-9","article-title":"Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke","volume":"11","author":"Orset","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2026.102645_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2019.12.021","article-title":"Evaluation of long-term rt-PA effects on bEnd.3 endothelial cells under ischemic conditions; changes in ZO-1 expression and glycosylation of the bradykinin B2 receptor","volume":"187","author":"Gubern","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.coph.2026.102645_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.23680","article-title":"Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas","volume":"72","author":"Kunte","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCRESAHA.120.317596","article-title":"tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke","volume":"128","author":"Shi","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2026.102645_bib30","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/S0140-6736(24)00921-8","article-title":"Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial","volume":"403","author":"Coutts","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2026.102645_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1474-4422(24)00206-0","article-title":"Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4\u00b75 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial","volume":"23","author":"Parsons","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coph.2026.102645_sref32","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/s41467-025-57774-x","article-title":"Edaravone dexborneol for ischemic stroke with sufficient recanalization after thrombectomy: a randomized phase II trial","volume":"16","author":"Chen","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102645_bib33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0140-6736(25)00194-1","article-title":"Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial","volume":"405","author":"Hill","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2026.102645_bib34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaneurol.2023.1871","article-title":"Efficacy and safety of butylphthalide in patients with acute ischemic stroke: a randomized clinical trial","volume":"80","author":"Wang","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107695","article-title":"Natural medicine in neuroprotection for ischemic stroke: challenges and prospective","volume":"216","author":"Tao","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2026.102645_bib36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12974-018-1124-6","article-title":"Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33\/ST2 axis-mediated microglia\/macrophage M2 polarization","volume":"15","author":"Jiang","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.coph.2026.102645_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119942","article-title":"Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke","volume":"243","author":"Kim","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.coph.2026.102645_bib38","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1001\/jama.2023.7827","article-title":"Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2026.102645_bib39","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","article-title":"Dual antiplatelet treatment up to 72 hours after ischemic stroke","volume":"389","author":"Gao","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2026.102645_sref40","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamaneurol.2024.0146","article-title":"Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial","volume":"81","author":"Chen","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamaneurol.2021.4514","article-title":"Comparison of ticagrelor vs clopidogrel in addition to aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis","volume":"79","author":"Lun","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib42","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1503\/cmaj.231262","article-title":"Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial","volume":"196","author":"Wang","year":"2024","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.coph.2026.102645_bib43","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijms22020954","article-title":"Impact of SMTP targeting plasminogen and soluble epoxide hydrolase on thrombolysis, inflammation, and ischemic stroke","volume":"22","author":"Hasumi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102645_bib44","article-title":"Safety and efficacy of GD-11 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"10","author":"Zhang","year":"2024","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-025-01573-1","article-title":"3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat","author":"Chen","year":"2025","journal-title":"GeroScience"},{"key":"10.1016\/j.coph.2026.102645_bib46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jpha.2023.06.010","article-title":"Protective effects of catalpol on cardio-cerebrovascular diseases: a comprehensive review","volume":"13","author":"Zhang","year":"2023","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.coph.2026.102645_bib47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpha.2022.12.002","article-title":"Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke","volume":"13","author":"Hong","year":"2023","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.coph.2026.102645_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1498","article-title":"Plasmin-resistant PSD-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke","volume":"13","author":"Mayor-Nunez","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2026.102645_sref49","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/STROKEAHA.124.048464","article-title":"Anti-Inflammatory thrombolytic JX10 (TMS-007) in late presentation of acute ischemic stroke","volume":"55","author":"Niizuma","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.coph.2026.102645_bib50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7150\/ijbs.14059","article-title":"Lyophilized powder of catalpol and puerarin protects neurovascular unit from stroke","volume":"12","author":"Xue","year":"2016","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.coph.2026.102645_bib51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7150\/ijbs.8571","article-title":"Amelioration of stroke-induced neurological deficiency by lyophilized powder of catapol and puerarin","volume":"10","author":"Liu","year":"2014","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.coph.2026.102645_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(25)00193-X","article-title":"Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study","volume":"405","author":"Christenson","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2026.102645_bib54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1474-4422(24)00515-5","article-title":"Safety and efficacy of nerinetide in patients with acute ischaemic stroke enrolled in the early window: a post-hoc meta-analysis of individual patient data from three randomised trials","volume":"24","author":"Tymianski","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib55","article-title":"Bone marrow mesenchymal stem cell-derived dermcidin-containing migrasomes enhance LC3-associated phagocytosis of pulmonary macrophages and protect against post-stroke pneumonia","volume":"10","author":"Li","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.coph.2026.102645_bib56","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1073\/pnas.2000690117","article-title":"Activity in grafted human iPS cell\u2013derived cortical neurons integrated in stroke-injured rat brain regulates motor behavior","volume":"117","author":"Palma-Tortosa","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2026.102645_sref57","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1038\/s41467-025-60187-5","article-title":"Forebrain neural progenitors effectively integrate into host brain circuits and improve neural function after ischemic stroke","volume":"16","author":"He","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102645_bib58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jamaneurol.2023.5200","article-title":"Allogeneic stem cell therapy for acute ischemic stroke: the phase 2\/3 TREASURE randomized clinical trial","volume":"81","author":"Houkin","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.coph.2026.102645_bib59","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","article-title":"Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke","volume":"96","author":"Chung","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.coph.2026.102645_bib60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41401-022-00986-4","article-title":"Humanized cerebral organoids-based ischemic stroke model for discovering of potential anti-stroke agents","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.coph.2026.102645_bib61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41580-024-00804-1","article-title":"Modelling human brain development and disease with organoids","volume":"26","author":"Birtele","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.coph.2026.102645_bib62","article-title":"The potential and therapeutic advances of the integrin family in neurological disorders","author":"Zhang","year":"2025","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.coph.2026.102645_bib63","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1002\/ptr.7994","article-title":"Advances of phytotherapy in ischemic stroke targeting PI3K\/Akt signaling","volume":"37","author":"Liu","year":"2023","journal-title":"Phytother Res"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148922600041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148922600041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:42:42Z","timestamp":1785962562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148922600041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":62,"alternative-id":["S147148922600041X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2026.102645","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the ischemic cascade: Review on approved and investigational stroke therapies","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2026.102645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102645"}}